Results 131 to 140 of about 247,667 (242)

Cannabinoids in Motor Control: From Receptor Distribution to Motor Disorders. [PDF]

Biomedicines
Faganeli D, Lipnik-Stangelj M.
europepmc   +1 more source

Minireview: From the bench, toward the clinic: therapeutic opportunities for cannabinoid receptor modulation.

Molecular Endocrinology, 2015
R. P. Picone, D. Kendall
semanticscholar   +1 more source

The Effect of SERM/CB₂ Receptor Modulators on Repetitive Behaviours in Juvenile and Young Adult Mice May Have Implications for Tourette Syndrome Treatment. [PDF]

Int J Mol Sci
Gorberg V, McCaffery P, Anavi-Goffer S.
europepmc   +1 more source

A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects

Neuropsychopharmacology, 2015
Bogna Marta Ignatowska-Jankowska, G. Baillie, S. Kinsey, M. Crowe, Sudeshna Ghosh, R. A. Owens, I. Damaj, J. Poklis, J. Wiley, M. Zanda, C. Zanato, I. Greig, A. Lichtman, R. Ross   +13 more
semanticscholar   +1 more source

Cannabinoid-Driven Rewiring of GPCR and Ion Channel Signaling in Lung Cancer. [PDF]

Biomedicines
Heriyanto DS, Nurkolis F, Choi J, Park S, Choi M, Tjandrawinata RR, Rani A, Park MN, Kwak MJ, Shim BS, Kim B.   +10 more
europepmc   +1 more source

Review: "The Disappointment Dilemma: Short- and Long-Term Learning From Negative Outcomes". [PDF]

Eur J Neurosci
Ibañez-Tallon I, Molas S, Proulx CD, Piriz J, Soria-Gómez E.   +4 more
europepmc   +1 more source

Circuit-Selective FAAH Inhibition Suppresses Experimental Absence Seizures. [PDF]

CNS Neurosci Ther
Morais TP, Bombardi C, Crunelli V, Di Giovanni G.   +3 more
europepmc   +1 more source

Dissecting GPCR Contributions to Gαo-Dependent Motor Dysfunction in <i>GNAO1</i>-Related Disorders Using <i>Caenorhabditis elegans</i>. [PDF]

Biomedicines
Di Rocco M, Di Rienzo L, Follo FC, D'Alessandro M, Galosi S, Pannone L, Venanzi S, Di Schiavi E, Martire A, Bessereau JL, Leuzzi V, Milanetti E, Martinelli S.   +12 more
europepmc   +1 more source

Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor

Proceedings of the National Academy of Sciences of the United States of America, 2012
F. Pamplona, J. Ferreira, Octávio Menezes de Lima, F. S. Duarte, A. Bento, S. Forner, J. G. Villarinho, L. Bellocchio, C. Wotjak, Raissa Lerner, K. Monory, B. Lutz, C. Canetti, I. Matias, J. Calixto, G. Marsicano, M. Guimarães, R. Takahashi   +17 more
semanticscholar   +1 more source

Modulating the endocannabinoid system in alcohol use disorder: A translational systematic review and meta-analysis of preclinical and human studies. [PDF]

Mol Psychiatry
Costa GPA, Cerezo-Matias MA, Funaro MC, Bagdas D, Kaye A, Krystal J, Petrakis I, De Aquino JP.   +7 more
europepmc   +1 more source